(Q38247018)

1 September 2017

1 reference

title

Noncoding RNAs and myocardial fibrosis (English)

1 reference

1 September 2017

Thomas Thum

1

1 reference

PubMed ID

25200283

1 September 2017

language of work or name

English

0 references

publication date

9 September 2014

1 reference

Nature Reviews Cardiology

1 September 2017

1 reference

1 September 2017

11

1 reference

1 September 2017

11

1 reference

1 September 2017

655-663

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

1 September 2017

1 reference

Cardiovascular remodelling in coronary artery disease and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

The arterial and cardiac epicardium in development, disease and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Landscape of transcription in human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Non-coding RNAs in cardiac remodeling and heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

microRNA therapeutics in cardiovascular disease models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Genome regulation by long noncoding RNAs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Long noncoding RNAs: cellular address codes in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Peptides encoded by short ORFs control development and define a new eukaryotic gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Long noncoding RNAs usher in a new era in the biology of enhancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Regulatory RNAs and paracrine networks in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Transforming growth factor-β-induced endothelial-to-mesenchymal transition is partly mediated by microRNA-21.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA-mediated epigenetic silencing of sirtuin1 contributes to impaired angiogenic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Molecular basis of cardiac endothelial-to-mesenchymal transition (EndMT): differential expression of microRNAs during EndMT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Control of stress-dependent cardiac growth and gene expression by a microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA expression in response to murine myocardial infarction: miR-21 regulates fibroblast metalloprotease-2 via phosphatase and tensin homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

A novel reciprocal loop between microRNA-21 and TGFβRIII is involved in cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

miR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving Programmed Cell Death 4 and Sprouty-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Myocardial and circulating levels of microRNA-21 reflect left ventricular fibrosis in aortic stenosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Comparison of different miR-21 inhibitor chemistries in a cardiac disease model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Sex- and estrogen-dependent regulation of a miRNA network in the healthy and hypertrophied heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Smad3 inactivation and MiR-29b upregulation mediate the effect of carvedilol on attenuating the acute myocardium infarction-induced myocardial fibrosis in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA-133 controls cardiac hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MiR-133a regulates collagen 1A1: potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Connective tissue growth factor and cardiac fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Macrophage microRNA-155 promotes cardiac hypertrophy and failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Transplantation of human pericyte progenitor cells improves the repair of infarcted heart through activation of an angiogenic program involving micro-RNA-132

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Deep RNA sequencing reveals dynamic regulation of myocardial noncoding RNAs in failing human heart and remodeling with mechanical circulatory support

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Impact of microRNA expression in human atrial tissue in patients with atrial fibrillation undergoing cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Role for MicroRNA-21 in atrial profibrillatory fibrotic remodeling associated with experimental postinfarction heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Role of miR-21 in the pathogenesis of atrial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Downregulation of miR-133 and miR-590 contributes to nicotine-induced atrial remodelling in canines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Fragmented and delayed electrograms within fibrofatty scar predict arrhythmic events in arrhythmogenic right ventricular cardiomyopathy: results from a prospective risk stratification study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Heart structure-specific transcriptomic atlas reveals conserved microRNA-mRNA interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Molecular signature of a right heart failure program in chronic severe pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Dynamic microRNA expression during the transition from right ventricular hypertrophy to failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA-34a regulates cardiac ageing and function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA-22 regulates cardiac hypertrophy and remodeling in response to stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Role of Mitogen-Activated Protein Kinases in Myocardial Ischemia-Reperfusion Injury during Heart Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Regulation of cardiac and renal ischemia-reperfusion injury by microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA and mRNA signatures in ischemia reperfusion injury in heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Conditioning techniques and ischemic reperfusion injury in relation to on-pump cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Circulating miRNAs reflect early myocardial injury and recovery after heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Wound healing and inflammation genes revealed by array analysis of 'macrophageless' PU.1 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Cardiotoxicity of anticancer treatments: what the cardiologist needs to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Let-7 g is involved in doxorubicin induced myocardial injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Heart repair by reprogramming non-myocytes with cardiac transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Reprogramming of human fibroblasts toward a cardiac fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Induction of human cardiomyocyte-like cells from fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Inefficient reprogramming of fibroblasts into cardiomyocytes using Gata4, Mef2c, and Tbx5

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Direct conversion of fibroblasts to neurons by reprogramming PTB-regulated microRNA circuits

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Detection and transport mechanisms of circulating microRNAs in neurological, cardiac and kidney diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Circulating miR-29a, among other up-regulated microRNAs, is the only biomarker for both hypertrophy and fibrosis in patients with hypertrophic cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Exosomes and cardiac repair after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA therapeutics in cardiovascular medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Adeno-associated virus-delivered polycistronic microRNA-clusters for knockdown of vascular endothelial growth factor in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

NF-κB mediated miR-26a regulation in cardiac fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

microRNA-122down-regulation may play a role in severe myocardial fibrosis in human aortic stenosis through TGF-β1up-regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

MicroRNA-29 in Aortic Dilation: Implications for Aneurysm Formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Hypertrophic cardiomyopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Cellular dedifferentiation of endothelium is linked to activation and silencing of certain nuclear transcription factors: implications for endothelial dysfunction and vascular biology.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Expression of MicroRNA-29 and Collagen in Cardiac Muscle after Swimming Training in Myocardial-Infarcted Rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Atrial remodeling and atrial fibrillation: recent advances and translational perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Non-coding RNAs in cardiovascular ageing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Circulating microRNAs as biomarkers and potential paracrine mediators of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

Genome-wide profiling of the cardiac transcriptome after myocardial infarction identifies novel heart-specific long non-coding RNAs

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRCARDIO.2014.125

10.1038/NRCARDIO.2014.125

31 March 2020

Identifiers

DOI

1 reference

1 September 2017

1 reference

PubMed ID

25200283